Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats

Texto completo
Autor(es):
Capitelli, Caroline ; Sereniki, Adriana ; Santos Lima, Marcelo Meira [1] ; Reksidler, Angela Braga ; Tufik, Sergio [1] ; Barbato Frazao Vital, Maria Aparecida [2]
Número total de Autores: 6
Afiliação do(s) autor(es):
[1] Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo - Brazil
[2] Univ Fed Parana, Dept Farmacol, Setor Ciencias Biol, BR-81531990 Curitiba, Parana - Brazil
Número total de Afiliações: 2
Tipo de documento: Artigo Científico
Fonte: European Journal of Pharmacology; v. 594, n. 1-3, p. 101-108, OCT 10 2008.
Citações Web of Science: 46
Resumo

Parkinson's disease is a chronic neurological disease characterized by dopaminergic neuron degeneration in the substantia nigra pars compacta. Melatonin is a powerful antioxidant agent secreted by the pineal gland which has numerous physiological functions and seems to exert an important neuroprotective effect. The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model has been used to understand the pathophysiology of the disease because of its capacity to mimic biochemical and histological features observed in Parkinson's disease. This study investigated the effect of pretreatment with melatonin (50 mg/kg) on MPTP-lesioned animals 24 h and 7 days after neurotoxin infusion using the open-field test, two-way avoidance task and immunohistochemistry. Twenty-four hours after lesioning, the MPTP+vehicle group exhibited hypolocomotion and significant loss of tyrosine hydroxylase-immunoreactive cells, whereas no differences in these parameters were observed in lesioned animals receiving melatonin. Seven days after surgery, the MPTP-lesioned rats did not show hypolocomotion compared to control animals, while there was a significant dopaminergic neuronal loss. In the two-way avoidance task, MPTP-treated animals presented a cognitive deficit compared to the control groups and melatonin administration did not repair this defect. The present results suggest that melatonin reduces neuronal loss in the MPTP animal model of Parkinson's disease. (C) 2008 Published by Elsevier B.V. (AU)

Processo FAPESP: 06/55968-6 - Análise da arquitetura do sono em modelos animais de parkinsonismo
Beneficiário:Marcelo de Meira Santos Lima
Linha de fomento: Bolsas no Brasil - Doutorado